| Title |
2017 Update of ESC/EAS Task Force on practical clinical guidance for proprotein convertase subtilisin/kexin type 9 inhibition in patients with atherosclerotic cardiovascular disease or in familial hypercholesterolaemia.
|
|---|---|
| Published in |
European Heart Journal, October 2017
|
| DOI | 10.1093/eurheartj/ehx549 |
| Pubmed ID | |
| Authors |
Ulf Landmesser, M John Chapman, Jane K Stock, Pierre Amarenco, Jill J F Belch, Jan Borén, Michel Farnier, Brian A Ference, Stephan Gielen, Ian Graham, Diederick E Grobbee, G Kees Hovingh, Thomas F Lüscher, Massimo F Piepoli, Kausik K Ray, Erik S Stroes, Olov Wiklund, Stephan Windecker, Jose Luis Zamorano, Fausto Pinto, Lale Tokgözoglu, Jeroen J Bax, Alberico L Catapano |
X Demographics
The data shown below were collected from the profiles of 44 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 12 | 27% |
| Italy | 3 | 7% |
| United States | 3 | 7% |
| United Kingdom | 2 | 5% |
| Colombia | 2 | 5% |
| Portugal | 1 | 2% |
| Paraguay | 1 | 2% |
| Guatemala | 1 | 2% |
| Chile | 1 | 2% |
| Other | 5 | 11% |
| Unknown | 13 | 30% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 27 | 61% |
| Practitioners (doctors, other healthcare professionals) | 12 | 27% |
| Scientists | 3 | 7% |
| Science communicators (journalists, bloggers, editors) | 2 | 5% |
Mendeley readers
The data shown below were compiled from readership statistics for 98 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 98 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Other | 20 | 20% |
| Researcher | 13 | 13% |
| Student > Doctoral Student | 8 | 8% |
| Student > Postgraduate | 5 | 5% |
| Student > Bachelor | 5 | 5% |
| Other | 16 | 16% |
| Unknown | 31 | 32% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 51 | 52% |
| Pharmacology, Toxicology and Pharmaceutical Science | 3 | 3% |
| Agricultural and Biological Sciences | 2 | 2% |
| Biochemistry, Genetics and Molecular Biology | 2 | 2% |
| Business, Management and Accounting | 1 | 1% |
| Other | 5 | 5% |
| Unknown | 34 | 35% |
Attention Score in Context
This research output has an Altmetric Attention Score of 27. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 31 December 2019.
All research outputs
#1,334,737
of 24,286,850 outputs
Outputs from European Heart Journal
#1,968
of 10,560 outputs
Outputs of similar age
#27,813
of 329,713 outputs
Outputs of similar age from European Heart Journal
#22
of 159 outputs
Altmetric has tracked 24,286,850 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 10,560 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 31.7. This one has done well, scoring higher than 81% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 329,713 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 91% of its contemporaries.
We're also able to compare this research output to 159 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 86% of its contemporaries.